Onabotulinum toxin-a versus extended release tolterodine in the management of idiopathic overactive bladder in children: A pilot randomized controlled trial (OVERT Trial)
Safety and efficacy of atezolizumab in patients with autoimmune disease: Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma
Trimodal therapy in T2‐4aN0M0 bladder cancer––How to select the best candidate?
Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma
Comparison of major complications at 30 and 90 days following radical cystectomy
Views of normal bladder function among women experiencing lower urinary tract symptoms
Most read this week